Crossmark

Off-Label Use of Antipsychotic Agents in Dementia: Evidence for the Revision of the Reimbursement Policy

Crossref DOI link: https://doi.org/10.1177/2168479018795857

Published Online: 2019-12-23

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stakišaitis, Donatas

Zamarytė-Sakavičienė, Kristina

Lesauskaitė, Vita

Jankūnas, Rimas Jonas
License Information

Text and Data Mining valid from 2019-07-01
More Information

Article History

Received: 3 April 2018

Accepted: 30 July 2018

First Online: 23 December 2019